engleski

Antithrombotic therapy for eye surgery: new approaches

Increasing number of patients undergoing eye surgery are elderly. They are usually on antithrombotic therapy. These drugs may increase risk of perioperative bleeding associated with ophthalmic needle blocks and/or eye surgery. Intraoperative bleeding and postoperative hemorrhagic complications may lead to the loss of visual function or even eye. On the other hand, stopping anticoagulant and antiplatelet agents before the surgery may put the ophthalmic patients to higher thrombotic risk with potentially life-threatening complications. The aim of this narrative review is to provide systematic analysis of the published evidence on the perioperative antithrombotic management of ophthalmic patients who are planned for different types of eye surgery in ambulatory settings.

antithrombotics, eye surgery

nije evidentirano